What question did this study set out to answer?

Evaluate the effectiveness of reduced-frequency GLP1 therapy in maintaining improvements in weight and metabolic syndrome.

February 26, 20266 citations

View Full Paper

Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series.

MWMichelle WongWestern University AWAsh WuSamuel Merritt University PGPawanjot K GarheUniversity of California, San Diego

Key Points

Evaluate the effectiveness of reduced-frequency GLP1 therapy in maintaining improvements in weight and metabolic syndrome.
Conducted a case series analysis of patients on GLP1 therapy
Assessed weight, body composition, and metabolic improvements after reducing dosing frequency
Monitored outcomes over a specified follow-up period
Reduced-frequency therapy maintained weight and body composition
Metabolic syndrome improvements were preserved with de-escalation
Findings suggest reduced treatment burden without sacrificing efficacy

Abstract

In patients with prior weight loss and metabolic improvement on GLP1 therapy, reduced-frequency maintenance dosing preserved outcomes. These findings support structured de-escalation as a promising strategy to reduce treatment burden without sacrificing efficacy.

AI से पूछें

Bookmark

View Full Paper

AI से पूछें

Bookmark

View Full Paper

Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series.

Key Points

Abstract

Cite This Study

Also Consider

Also Consider